A detailed history of Manufacturers Life Insurance Company, The transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 37,813 shares of KURA stock, worth $340,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,813
Previous 38,536 1.88%
Holding current value
$340,695
Previous $793,000 6.94%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$18.57 - $23.23 $13,426 - $16,795
-723 Reduced 1.88%
37,813 $738,000
Q2 2024

Aug 14, 2024

BUY
$17.53 - $22.98 $34,639 - $45,408
1,976 Added 5.4%
38,536 $793,000
Q1 2024

May 14, 2024

BUY
$13.42 - $23.53 $116,955 - $205,063
8,715 Added 31.3%
36,560 $779,000
Q4 2023

Feb 13, 2024

BUY
$7.58 - $14.38 $7,382 - $14,006
974 Added 3.62%
27,845 $400,000
Q3 2023

Nov 15, 2023

BUY
$8.44 - $11.86 $9,410 - $13,223
1,115 Added 4.33%
26,871 $245,000
Q2 2023

Aug 11, 2023

BUY
$9.62 - $13.99 $11,284 - $16,410
1,173 Added 4.77%
25,756 $272,000
Q4 2022

Aug 11, 2023

SELL
$11.23 - $16.9 $2,189 - $3,295
-195 Reduced 0.79%
24,583 $305,000
Q4 2022

Feb 13, 2023

SELL
$11.23 - $16.9 $2,189 - $3,295
-195 Reduced 0.79%
24,583 $305,000
Q3 2022

Aug 11, 2023

SELL
$12.01 - $19.45 $7,061 - $11,436
-588 Reduced 2.32%
24,778 $338,000
Q3 2022

Nov 03, 2022

SELL
$12.01 - $19.45 $7,061 - $11,436
-588 Reduced 2.32%
24,778 $338,000
Q2 2022

Aug 11, 2023

SELL
$10.71 - $18.33 $12,659 - $21,666
-1,182 Reduced 4.45%
25,366 $464,000
Q2 2022

Aug 15, 2022

SELL
$10.71 - $18.33 $12,659 - $21,666
-1,182 Reduced 4.45%
25,366 $465,000
Q1 2022

Aug 11, 2023

BUY
$11.78 - $16.98 $23,147 - $33,365
1,965 Added 7.99%
26,548 $426,000
Q1 2022

May 20, 2022

SELL
$11.78 - $16.98 $81,340 - $117,246
-6,905 Reduced 20.64%
26,548 $427,000
Q4 2021

Feb 16, 2022

SELL
$12.22 - $19.57 $1,356 - $2,172
-111 Reduced 0.33%
33,453 $468,000
Q3 2021

Nov 12, 2021

SELL
$15.42 - $21.72 $36,252 - $51,063
-2,351 Reduced 6.55%
33,564 $629,000
Q2 2021

Aug 12, 2021

BUY
$20.85 - $29.88 $14,344 - $20,557
688 Added 1.95%
35,915 $749,000
Q1 2021

May 03, 2021

SELL
$24.75 - $39.14 $30,195 - $47,750
-1,220 Reduced 3.35%
35,227 $996,000
Q4 2020

Feb 12, 2021

BUY
$29.0 - $41.62 $169,476 - $243,227
5,844 Added 19.1%
36,447 $1.19 Million
Q3 2020

Nov 09, 2020

SELL
$16.3 - $30.64 $17,392 - $32,692
-1,067 Reduced 3.37%
30,603 $938,000
Q2 2020

Aug 10, 2020

BUY
$7.95 - $18.81 $71,359 - $168,838
8,976 Added 39.55%
31,670 $525,000
Q1 2020

May 15, 2020

BUY
$6.45 - $14.04 $9,378 - $20,414
1,454 Added 6.85%
22,694 $226,000
Q4 2019

Feb 14, 2020

BUY
$12.97 - $15.94 $596 - $733
46 Added 0.22%
21,240 $292,000
Q3 2019

Nov 12, 2019

BUY
$14.75 - $20.87 $38,202 - $54,053
2,590 Added 13.92%
21,194 $313,000
Q2 2019

Aug 14, 2019

BUY
$14.71 - $19.79 $115,826 - $155,826
7,874 Added 73.38%
18,604 $366,000
Q1 2019

May 13, 2019

BUY
$13.73 - $16.87 $147,322 - $181,015
10,730 New
10,730 $178,000
Q4 2018

Feb 14, 2019

SELL
$10.6 - $17.49 $112,635 - $185,848
-10,626 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$16.65 - $21.85 $147,385 - $193,416
-8,852 Reduced 45.45%
10,626 $186,000
Q2 2018

Aug 14, 2018

BUY
$14.8 - $18.8 $39,886 - $50,666
2,695 Added 16.06%
19,478 $355,000
Q1 2018

May 15, 2018

BUY
$14.5 - $23.4 $12,861 - $20,755
887 Added 5.58%
16,783 $315,000
Q4 2017

Feb 08, 2018

SELL
$13.5 - $16.65 $9,963 - $12,287
-738 Reduced 4.44%
15,896 $243,000
Q3 2017

Nov 14, 2017

BUY
$6.05 - $14.95 $100,635 - $248,678
16,634
16,634 $249,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $603M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.